EDITORIAL
Published on 27 Sep 2022
Editorial: Targeting DNA repair and the DNA damage response: Beyond the standard PI3 kinase-like kinases
doi 10.3389/fonc.2022.1023500
- 795 views
- Frontiers in Oncology
- Cancer Molecular Targets and Therapeutics
- Research Topics
- Targeting DNA Repair and the DNA Damage Response: Beyond the Standard PI3 Kinase-like Kinases
Targeting DNA Repair and the DNA Damage Response: Beyond the Standard PI3 Kinase-like Kinases
18k
Total Downloads
66k
Total Views and Downloads
Submit your idea
You will be redirected to our submission process.
Articles
ORIGINAL RESEARCH
Published on 13 May 2022
Targeting the Homologous Recombination Pathway in Cancer With a Novel Class of RAD51 Inhibitors
doi 10.3389/fonc.2022.885186
- 3,357 views
- 4 citations
REVIEW
Published on 21 Apr 2022
Xeroderma Pigmentosum Complementation Group C (XPC): Emerging Roles in Non-Dermatologic Malignancies
doi 10.3389/fonc.2022.846965
- 3,990 views
- 12 citations
REVIEW
Published on 06 Apr 2022
Recent Advances in the Development of Non-PIKKs Targeting Small Molecule Inhibitors of DNA Double-Strand Break Repair
doi 10.3389/fonc.2022.850883
- 4,955 views
- 16 citations
ORIGINAL RESEARCH
Published on 24 Mar 2022
RelA Is an Essential Target for Enhancing Cellular Responses to the DNA Repair/Ref-1 Redox Signaling Protein and Restoring Perturbated Cellular Redox Homeostasis in Mouse PDAC Cells
doi 10.3389/fonc.2022.826617
- 3,696 views
- 6 citations
ORIGINAL RESEARCH
Published on 17 Mar 2022
Modulation of ERCC1-XPF Heterodimerization Inhibition via Structural Modification of Small Molecule Inhibitor Side-Chains
doi 10.3389/fonc.2022.819172
- 2,770 views
- 8 citations
ORIGINAL RESEARCH
Published on 16 Mar 2022
Nuclear Receptor PXR Confers Irradiation Resistance by Promoting DNA Damage Response Through Stabilization of ATF3
doi 10.3389/fonc.2022.837980
- 1,943 views
- 10 citations
BRIEF RESEARCH REPORT
Published on 10 Mar 2022
Chemical Biology Screening Identifies a Vulnerability to Checkpoint Kinase Inhibitors in TSC2-Deficient Renal Angiomyolipomas
doi 10.3389/fonc.2022.852859
- 1,794 views
- 2 citations
ORIGINAL RESEARCH
Published on 18 Feb 2022
In Vivo Targeting Replication Protein A for Cancer Therapy
doi 10.3389/fonc.2022.826655
- 3,064 views
- 10 citations
REVIEW
Published on 17 Feb 2022
Targeting the DNA Damage Response for Cancer Therapy by Inhibiting the Kinase Wee1
doi 10.3389/fonc.2022.828684
- 7,747 views
- 35 citations
REVIEW
Published on 07 Feb 2022
DNA Damage Tolerance Pathways in Human Cells: A Potential Therapeutic Target
doi 10.3389/fonc.2021.822500
- 5,729 views
- 16 citations
MINI REVIEW
Published on 28 Jan 2022
Metnase and EEPD1: DNA Repair Functions and Potential Targets in Cancer Therapy
doi 10.3389/fonc.2022.808757
- 1,962 views
- 13 citations
Published in
Frontiers in Oncology
- Cancer Molecular Targets and Therapeutics
Participating Journals
Frontiers in Pharmacology
Cancer Molecular Targets and TherapeuticsOffline
- 4.4 impact factor
- 7.8 citescore
Impact
- 66kTopic views
- 47kArticle views
- 18kArticle downloads